Molecular Pathogenesis of Hepatocellular Carcinoma

被引:77
作者
Ho, Daniel Wai-Hung [1 ,2 ]
Lo, Regina Cheuk-Lam [1 ,2 ]
Chan, Lo-Kong [1 ,2 ]
Ng, Irene Oi-Lin [1 ,2 ]
机构
[1] Univ Hong Kong, Dept Pathol, Room 127B,Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Liver Res, Room 127B,Univ Pathol Bldg, Pokfulam, Hong Kong, Peoples R China
关键词
Cancer stem cells; Hepatocellular carcinoma; Molecular alterations; Next-generation sequencing; CANCER STEM-CELLS; TERT PROMOTER MUTATIONS; TUMOR-INITIATING CELLS; LONG NONCODING RNA; NF-KAPPA-B; LIVER-CANCER; SELF-RENEWAL; SORAFENIB RESISTANCE; RECURRENT MUTATIONS; SIGNALING PATHWAYS;
D O I
10.1159/000449340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pathogenesis of hepatocellular carcinoma (HCC) is a multistep process involving the progressive accumulation of molecular alterations pinpointing different molecular and cellular events. The next-generation sequencing technology is facilitating the global and systematic evaluation of molecular landscapes in HCC. There is emerging evidence supporting the importance of cancer metabolism and tumor microenvironment in providing a favorable and supportive niche to expedite HCC development. Moreover, recent studies have identified distinct surface markers of cancer stem cell (CSC) in HCC, and they also put forward the profound involvement of altered signaling pathways and epigenetic modifications in CSCs, in addition to the concomitant drug resistance and metastasis. Taken together, multiple key genetic and non-genetic factors, as well as liver CSCs, result in the development and progression of HCC. Copyright (C) 2016 S. Karger AG, Basel
引用
收藏
页码:290 / 302
页数:13
相关论文
共 92 条
[1]  
Amann T, 2010, CURR OPIN GENE DEV, V20, P51
[2]   GLUT1 as a therapeutic target in hepatocellular carcinoma [J].
Amann, Thomas ;
Hellerbrand, Claus .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (12) :1411-1427
[3]   GLUT1 Expression Is Increased in Hepatocellular Carcinoma and Promotes Tumorigenesis [J].
Amann, Thomas ;
Maegdefrau, Ulrike ;
Hartmann, Arndt ;
Agaimy, Abbas ;
Marienhagen, Joerg ;
Weiss, Thomas S. ;
Stoeltzing, Oliver ;
Warnecke, Christina ;
Schoelmerich, Juergen ;
Oefner, Peter J. ;
Kreutz, Marina ;
Bosserhoff, Anja K. ;
Hellerbrand, Claus .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (04) :1544-1552
[4]   Regulation of cancer cell metabolism [J].
Cairns, Rob A. ;
Harris, Isaac S. ;
Mak, Tak W. .
NATURE REVIEWS CANCER, 2011, 11 (02) :85-95
[5]   Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133 [J].
Chai, Stella ;
Tong, Man ;
Ng, Kai Yu ;
Kwan, Pak Shing ;
Chan, Yuen Piu ;
Fung, Tsun Ming ;
Lee, Terence K. ;
Wong, Nathalie ;
Xie, Dan ;
Yuan, Yun-Fei ;
Guan, Xin-Yuan ;
Ma, Stephanie .
ONCOTARGET, 2014, 5 (14) :5725-5735
[6]   Turning Hepatic Cancer Stem Cells Inside Out - A Deeper Understanding through Multiple Perspectives [J].
Chan, Lok-Hei ;
Luk, Steve T. ;
Ma, Stephanie .
MOLECULES AND CELLS, 2015, 38 (03) :202-209
[7]   Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma [J].
Chen, Zhiao ;
Lu, Xinyuan ;
Wang, Zhichao ;
Jin, Guangzhi ;
Wang, Qifeng ;
Chen, Di ;
Chen, Taoyang ;
Li, Jinjun ;
Fan, Jia ;
Cong, Wenming ;
Gao, Qiang ;
He, Xianghuo .
ONCOTARGET, 2015, 6 (04) :2539-2548
[8]  
Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
[9]   Identification of Driver Genes in Hepatocellular Carcinoma by Exome Sequencing [J].
Cleary, Sean P. ;
Jeck, William R. ;
Zhao, Xiaobei ;
Chen, Kui ;
Selitsky, Sara R. ;
Savich, Gleb L. ;
Tan, Ting-Xu ;
Wu, Michael C. ;
Getz, Gad ;
Lawrence, Michael S. ;
Parker, Joel S. ;
Li, Jinyu ;
Powers, Scott ;
Kim, Hyeja ;
Fischer, Sandra ;
Guindi, Maha ;
Ghanekar, Anand ;
Chiang, Derek Y. .
HEPATOLOGY, 2013, 58 (05) :1693-1702
[10]   The cancer stem cell: premises, promises and challenges [J].
Clevers, Hans .
NATURE MEDICINE, 2011, 17 (03) :313-319